The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
Authors
Keywords
-
Journal
AIDS
Volume 26, Issue 10, Pages 1231-1241
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-06-15
DOI
10.1097/qad.0b013e32835521a3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of sexual transmission of HIV
- (2012) Marie Laga et al. AIDS
- The design and evaluation of HIV-1 vaccines
- (2012) Kevin O. Saunders et al. AIDS
- Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses
- (2011) J. Capeau CLINICAL INFECTIOUS DISEASES
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals
- (2010) Ard van Sighem et al. AIDS
- Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection
- (2010) David A. Cooper et al. JOURNAL OF INFECTIOUS DISEASES
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
- (2010) Julio SG Montaner et al. LANCET
- Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
- (2009) Richard H Haubrich et al. AIDS
- Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
- (2009) Benoît Marin et al. AIDS
- The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
- (2009) Jose R Arribas et al. AIDS
- Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time
- (2009) Viviane D Lima et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
- (2009) Edwin DeJesus et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
- (2009) Jeffrey L Lennox et al. LANCET
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Challenge of Finding a Cure for HIV Infection
- (2009) D. D. Richman et al. SCIENCE
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
- (2008) Jean-Michel Molina et al. LANCET
- Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
- (2008) Sharon A. Riddler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
- (2008) Roy T. Steigbigel et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started